期刊文献+

孕妇体重,孕周因素对产前筛查血清学指标的影响 被引量:13

Maternal Weight,Gestational Factors on the Prenatal Screening of Serum Indicators of the ImPact Study
暂未订购
导出
摘要 目的探讨孕妇体重,孕周对孕中期唐氏综合征(DS)产前筛查血清学指标的影响。方法对2371例孕中期(15~22周)孕妇血清进行3项指标检测,利用统计软件Curve Expert1.3拟合出随着不同体重,孕周3项指标中位数变化的曲线。结果AFP,FE3随着孕周升高,ThCG随着孕周降低,3条曲线的相关系数r分别为0.998,0.999,0.990。AFP,ThCG随体重上升而下降,曲线的相关系数分别为0.995,0.930。FE3在体重组之间无差别,方差分析P>0.05。结论不同体重,孕周3项指标中位数变化的曲线,对唐氏筛查高风险的统计具有一定的影响因素。 Objectives Discussion Pregnant weight, gestational age of second--trimester Down syndrome(DS)Prenatal screening serological indicators. Methods 2371 cases of second trimester (15-22weeks)maternal serum for three indicators of detection,The use of statistical software CurveExpert 1.3 fitted with a different weight, gestational age of three indicators of changes in the median curve. Results AFP,EF3 levels rise with gestational age. ThCG level goes down with gestational weeks.The coefficient of correlation is 0.998,0.999, 0.990, respectively. AFP, ThCG levels decrease as the mother body weight rises,the coefficient of correlation is 0.995,0.930.EF3 shows no difference in different weight groups.Though ANOVA,P〉0.05.Conclusions Different weight, gestational age of three indicators of changes in the median curve, Screening high--risk for Down's statistics have a certain factor.
出处 《中外医疗》 2009年第19期15-16,共2页 China & Foreign Medical Treatment
关键词 唐氏综合征 甲胎蛋白 绒毛膜促性腺激素 游离雌三醇 Down' s syndrome=Alpha feto Protein Total beta human chronic gonadotropin Unconjugated estriol
  • 相关文献

参考文献6

二级参考文献19

  • 1Merkatz IK,Nitowaky HM,Macri JN,et al.An association between low matemal serum alpha-fetoprotein and fetal chromosome sbnormalities.Am J Obstet Gynecol.1987,148:886-894.
  • 2Cucckle HS,Wald NJ,Lindenbaum RH.Maternal serum alpha-fetoprotein messurement:a acreening test for Down's syndrome.Lancet.1984,1:926-929.
  • 3Canick JA,Knight GJ,Palomaki GE,et al.low second tripester maternal serum estriol in Down syndrome oregnancies.Am J Hum Genet.1987,41:A269.
  • 4Canick JA,Knight GJ,Palomaki GE,et al.Second trimester matemal derum umconjuated cestriol in pregnancies with Down's syndrome.Br J Obestet Gynaecol,1988,95:330-333.
  • 5Bogart MH ,Pandian MR,Jones OW.Abnormal matermal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnomalities ,prenat Diagn.1987,7:623-630.
  • 6Wald NJ,Cuckle HS,Densem JW,Maternal derum screening for Down's syndrome in early pregnancy.Br Med J.1988,297:883-887.
  • 7Haddow JE,Palomaki GE,Knight GJ,et al.Prenatal Screening for Down Syndrome with the Use of Maternal Serum Markers,N Eng J MED,1992,327:588-593.
  • 8Mooeny RA,Peserson CJ,French CA,et al.Effectiveness of combining maternal derum AFP and human chorionic gonadotropin in a second trimsster screening program for down syndrome.Obstet Gynecol,1994,84:298-303.
  • 9Macri JK,Kasturi RV,KRantz DA et al.Maternal serum Down dyndrome screening :free beta protein is a more effective marloer than human chorionic gonadotropin,Am J Obster Gynecol,1990,163:1248-1253.
  • 10Wald N,Cuolde H,Wu T,George L,Maternal derum unconjugated oestriol and human chorionic gonadotropin levels in twin pregnancies:implications for screening for Down's syndrome.Br J Obstet Gynaecol,1991,98:905-908.

共引文献61

同被引文献88

引证文献13

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部